Price T Rowe Associates Inc. MD increased its holdings in Global Medical REIT Inc. (NYSE:GMRE - Free Report) by 39.0% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 228,821 shares of the company's stock after buying an additional 64,164 shares during the period. Price T Rowe Associates Inc. MD owned 0.34% of Global Medical REIT worth $1,767,000 as of its most recent SEC filing.
Other large investors have also recently modified their holdings of the company. Franklin Resources Inc. grew its stake in shares of Global Medical REIT by 228.9% in the third quarter. Franklin Resources Inc. now owns 114,988 shares of the company's stock worth $1,073,000 after purchasing an additional 80,030 shares during the last quarter. Barclays PLC raised its position in shares of Global Medical REIT by 87.1% in the 3rd quarter. Barclays PLC now owns 154,051 shares of the company's stock worth $1,527,000 after purchasing an additional 71,704 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in Global Medical REIT during the 4th quarter valued at $1,430,000. New Age Alpha Advisors LLC bought a new stake in shares of Global Medical REIT in the 4th quarter worth $263,000. Finally, Aew Capital Management L P purchased a new position in shares of Global Medical REIT in the fourth quarter worth $230,000. Institutional investors own 57.52% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on GMRE shares. B. Riley started coverage on shares of Global Medical REIT in a research note on Thursday, April 3rd. They set a "neutral" rating and a $9.00 target price on the stock. Robert W. Baird decreased their target price on shares of Global Medical REIT from $10.00 to $9.00 and set a "neutral" rating for the company in a research note on Thursday.
Get Our Latest Analysis on Global Medical REIT
Global Medical REIT Price Performance
NYSE GMRE traded up $0.03 during trading hours on Monday, reaching $6.85. The company's stock had a trading volume of 759,541 shares, compared to its average volume of 450,359. The firm's 50-day moving average price is $8.00 and its 200-day moving average price is $8.22. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26. Global Medical REIT Inc. has a 1 year low of $6.75 and a 1 year high of $10.46. The company has a market capitalization of $457.73 million, a price-to-earnings ratio of -342.08, a PEG ratio of 1.43 and a beta of 1.23.
Global Medical REIT (NYSE:GMRE - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. The business had revenue of $34.60 million for the quarter, compared to analysts' expectations of $35.49 million. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. On average, equities research analysts predict that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.
Global Medical REIT Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, April 9th. Investors of record on Friday, March 21st were issued a dividend of $0.21 per share. The ex-dividend date of this dividend was Friday, March 21st. This represents a $0.84 annualized dividend and a yield of 12.27%. Global Medical REIT's payout ratio is presently 8,400.00%.
Global Medical REIT Company Profile
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Read More

Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.